PL107131B1 - Sposob wytwarzania estrow kwasu 5-bromonikotynowego - Google Patents
Sposob wytwarzania estrow kwasu 5-bromonikotynowego Download PDFInfo
- Publication number
- PL107131B1 PL107131B1 PL20287577A PL20287577A PL107131B1 PL 107131 B1 PL107131 B1 PL 107131B1 PL 20287577 A PL20287577 A PL 20287577A PL 20287577 A PL20287577 A PL 20287577A PL 107131 B1 PL107131 B1 PL 107131B1
- Authority
- PL
- Poland
- Prior art keywords
- acid
- general formula
- physiologically acceptable
- reacted
- acid esters
- Prior art date
Links
- FQIUCPGDKPXSLL-UHFFFAOYSA-N 5-bromopyridine-3-carboxylic acid Chemical class OC(=O)C1=CN=CC(Br)=C1 FQIUCPGDKPXSLL-UHFFFAOYSA-N 0.000 title claims description 3
- 239000002253 acid Substances 0.000 claims description 18
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 12
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003729 cation exchange resin Substances 0.000 claims description 4
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- DGPBVJWCIDNDPN-UHFFFAOYSA-N 2-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC=C1C=O DGPBVJWCIDNDPN-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- FMDREJRIXNEGEG-UHFFFAOYSA-N 5-bromopyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CN=CC(Br)=C1 FMDREJRIXNEGEG-UHFFFAOYSA-N 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000002160 alpha blocker Substances 0.000 description 1
- 229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- DCBDOYDVQJVXOH-UHFFFAOYSA-N azane;1h-indole Chemical compound N.C1=CC=C2NC=CC2=C1 DCBDOYDVQJVXOH-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| YU312976A YU39278B (en) | 1976-12-22 | 1976-12-22 | Process for preparing 5-bromo nicotinic acid esters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL202875A1 PL202875A1 (pl) | 1978-07-31 |
| PL107131B1 true PL107131B1 (pl) | 1980-01-31 |
Family
ID=25559391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20287577A PL107131B1 (pl) | 1976-12-22 | 1977-12-12 | Sposob wytwarzania estrow kwasu 5-bromonikotynowego |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5384996A (enExample) |
| DD (1) | DD133665A1 (enExample) |
| DE (1) | DE2752533C3 (enExample) |
| FR (1) | FR2375230A1 (enExample) |
| GB (1) | GB1557506A (enExample) |
| PL (1) | PL107131B1 (enExample) |
| SU (1) | SU645580A3 (enExample) |
| YU (1) | YU39278B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1094965B (it) * | 1978-04-05 | 1985-08-10 | Corvi Mora E | Procedimento di preparazione di derivati del lisergolo |
| JPS5661376A (en) * | 1979-10-09 | 1981-05-26 | Corvi Mora E | Manufacture of lysergol derivative |
| GB2173189B (en) * | 1985-02-21 | 1988-04-27 | Maruko Pharmaceutical Co | Ergoline derivatives and salts thereof and pharmaceutical compositions thereof |
| HU193782B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof |
| GB8612366D0 (en) * | 1986-05-21 | 1986-06-25 | Erba Farmitalia | Ergoline esters |
| GB9603226D0 (en) * | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Heterocyclyl-ergoline derivatives |
| FR2786099B1 (fr) * | 1998-11-24 | 2000-12-29 | Aventis Laboratoire | Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline |
| FR2786101B1 (fr) * | 1998-11-24 | 2002-07-05 | Aventis Laboratoire | Utilisation de la nicergoline dans le traitement de la spasticite |
| JP4845861B2 (ja) * | 2007-11-09 | 2011-12-28 | 興研株式会社 | 使い捨て式防じんマスク |
-
1976
- 1976-12-22 YU YU312976A patent/YU39278B/xx unknown
-
1977
- 1977-11-24 DE DE19772752533 patent/DE2752533C3/de not_active Expired
- 1977-11-30 SU SU772547851A patent/SU645580A3/ru active
- 1977-12-01 DD DD20235277A patent/DD133665A1/xx unknown
- 1977-12-02 JP JP14405277A patent/JPS5384996A/ja active Granted
- 1977-12-06 GB GB5073977A patent/GB1557506A/en not_active Expired
- 1977-12-12 PL PL20287577A patent/PL107131B1/pl unknown
- 1977-12-20 FR FR7738364A patent/FR2375230A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5512909B2 (enExample) | 1980-04-04 |
| JPS5384996A (en) | 1978-07-26 |
| SU645580A3 (ru) | 1979-01-30 |
| PL202875A1 (pl) | 1978-07-31 |
| DE2752533A1 (de) | 1978-06-29 |
| YU312976A (en) | 1982-08-31 |
| DE2752533B2 (de) | 1980-01-17 |
| FR2375230B1 (enExample) | 1983-01-14 |
| DD133665A1 (de) | 1979-01-17 |
| GB1557506A (en) | 1979-12-12 |
| DE2752533C3 (de) | 1980-09-18 |
| YU39278B (en) | 1984-10-31 |
| FR2375230A1 (fr) | 1978-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1468426A3 (ru) | Способ получени 9-оксима 6-О-метилэритромицина А | |
| Gutsche et al. | Calixarenes. 25. Conformations and structures of the products of arylmethylation of calix [4] arenes | |
| PL107131B1 (pl) | Sposob wytwarzania estrow kwasu 5-bromonikotynowego | |
| EP0055431B1 (de) | Verfahren zur Herstellung von 1,5-Didesoxy-1,5-imino-D-glucitol und dessen N-Derivaten | |
| JP2022538491A (ja) | ハイスループット化合物ライブラリー構築とスクリーニング方法および反応装置 | |
| CS197271B1 (en) | Process for preparing derivatives of rifamycine | |
| Hoffman et al. | Ionization of N-arylsulfonyloxy amines: the nitrenium ion question | |
| Politanskaya et al. | p-Toluenesulfonic acid induced conversion of fluorinated trimethylsilylethynylanilines into aminoacetophenones: versatile precursors for the synthesis of benzoazaheterocycles | |
| Zaderenko et al. | Synthesis and regioselective hydrolysis of 2-(imidazol-1-yl) succinic esters | |
| EP3063154B1 (en) | Cross-coupling of unactivated secondary boronic acids | |
| Benítez et al. | Intramolecular Oxidation of the Alcohol Functionalities in Hydroxyalkyl‐N‐Heterocyclic Carbene Complexes of Iridium and Rhodium | |
| CN106111190B (zh) | 一种手性联芳骨架吡哆胺类催化剂及其合成方法与应用 | |
| CN117677615A (zh) | 一种螺环化合物的盐型、晶型及其制备方法 | |
| CN112028849A (zh) | 一种帕瑞昔布钠杂质化合物的制备方法 | |
| JP2663105B2 (ja) | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン水和物結晶及びその製造法 | |
| Tsukamoto et al. | Metabolism of Drugs. XXXIX. Further Studies on Carbamate N-Glucuronide Formation in Animal Body. | |
| Ballester-Rodes et al. | N, N-Bis (2-Oxo-3-Oxazolidinyl) Phosphordiamidic Chloride (CLSPO): A New Strategy for the Ester Function Preparation | |
| CN114773333A (zh) | 一种卤代三唑并吡啶的合成方法 | |
| CA2404680C (en) | Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds | |
| CN117551035A (zh) | 一种含氮三取代烯烃型化合物及其制备方法和应用 | |
| Liang et al. | Molecular recognition with C‐clamp porphyrins: Synthesis, structural, and complexation studies | |
| CN108774261B (zh) | 一种氘代甲基对硫磷的制备方法 | |
| Miyano et al. | Synthesis of 5, 9, 9-trisubstituted 1-azabicyclo [3.3. 1] nonanes and their conformational analyses | |
| CN118724814A (zh) | 一种体外合成n-去甲基青藤碱方法 | |
| JP4587529B2 (ja) | イピダクリン及び塩酸イピダクリン水和物の製造方法 |